-transparent.png){kind=logo}
Hyperprolactinemia can be treated medically. Thus all patients with a normal sella turcica and those patients with only slight enlargement of the sella turcica can be treated medically with the dopaminagonist bromocriptine. This treatment is also indicated in paitents with postoperative persisting hyperprolactinemia. In contrast to hyperprolactinemia medical therapy of acromegaly is still in the experimental stage, through the dopaminagonist bromocriptine induces a decrease of growth hormone levels and improvement of the disease in many patients with acromegaly.
Related Publications
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
May 1983,
Schweizerische medizinische Wochenschrift,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
November 1983,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
January 2004,
Krankenpflege Journal,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
June 1977,
Horumon to rinsho. Clinical endocrinology,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
June 1989,
Harefuah,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
April 2005,
Problemy endokrinologii,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
September 2013,
Orvosi hetilap,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
May 1994,
European journal of endocrinology,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
January 1986,
Casopis lekaru ceskych,
K von Werder, and
T Eversmann, and
R Fahlbusch, and
H K Rjosk
October 1985,
Deutsche medizinische Wochenschrift (1946),
